When was Unlearn founded?

Unlearn was founded in 2017 and raised its 1st funding round 3 years after it was founded.

Where is Unlearn located?

Unlearn is headquartered in San Francisco, United States.

How many employees does Unlearn have?

As of Jun 30, 2026, the latest employee count at Unlearn is 75.

Is Unlearn a funded company?

Unlearn is a funded company, having raised a total of $135M across 6 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jan 30, 2020.

How much is Unlearn worth?

The latest valuation of Unlearn is $***** as of Mar 21, 2023.

When was the latest funding round of Unlearn?

Unlearn's latest funding was a $***** Series C round on Jan 25, 2024, with participation from 9 investors.

Where does Unlearn rank among its competitors?

Unlearn ranks 1st amongst 42 active competitors, of which 15 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Ryght, which secured an undisclosed amount in Dec, 2025.

Who are the top competitors of Unlearn?

Unlearn's top competitors include Ryght, Virtonomy and Ebenbuild. Among them, Ryght secured the most recent funding round in December, 2025.

Unlearn - 2026 Company Profile, Team, Funding & Competitors

Unlearn is a series C company based in San Francisco (United States), founded in 2017 by Charles Fisher. It operates as a Developer of an AI platform for clinical trial design and analysis. Unlearn has raised $135M in funding from investors like Insight Partners, EPIC Ventures and Altimeter Capital, with a current valuation of $*****. The company has 42 active competitors, including 15 that are funded. Its top competitors include companies like Ryght, Virtonomy and Ebenbuild.

Company Details

Developer of an AI platform for clinical trial design and analysis. The platform provides tools for trial design, literature review, data exploration, and scenario building. It offers digital twins to forecast clinical trial participant outcomes. The platform aims to improve decision-making and efficiency in clinical development.

Website: www.unlearn.ai/
Social

Key Metrics

Founded Year

2017

Location

San Francisco, United States

Stage

Series C

Total Funding

$135M in 6 rounds

Latest Funding Round

Series C, Jan 25, 2024, $*****

Post Money Valuation

$***** as on Mar 21, 2023

Investors

Insight Partners & 15 more

Ranked

1^st among 42 active competitors

Employee Count

75 as on Jun 30, 2026

Similar Companies

OpenEvidence & 2578 more

View Unlearn's full profile

Unlearn has raised a total funding of $135M over 6 rounds. Its first funding round was on Jan 30, 2020. Its latest funding round was a Series C round on Jan 25, 2024 for $*****. 9 investors participated in its latest round. Unlearn has 15 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of Unlearn:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 25, 2024	5755667	Series C	5253643	9062455	5161632	7159767
Mar 21, 2023	6764406	Series B	2370047	9567735	3106645	5259803
Apr 18, 2022	2265108	Series B	2581201	9847769	Global Ventures & 1 more	Radical Ventures & 4 more

Access funding benchmarks and valuations. Sign up today!

View details of Unlearn's funding rounds and investors

The founders of Unlearn is Charles Fisher. Steven Herne is the CEO of Unlearn.

Here are the details of Unlearn's key team members:

Charles Fisher: Former Co-Founder of Unlearn and founder of 1 other company. They serve on the boards of 2 companies.
Steven Herne: CEO of Unlearn.
Contact Info: 1 email address

View details of Unlearn's Founder profiles and Board Members

Unlearn's employee count trend

Unlearn has 75 employees as of Jun 26. Here is Unlearn's employee count trend over the years:

Uncover Unlearn's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Unlearn include Ryght, Virtonomy and Ebenbuild. Here is the list of Top 10 competitors of Unlearn, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Unlearn 2017, San Francisco (United States), Series C	Developer of an AI platform for clinical trial design and analysis	$135M	EPIC Ventures, Mubadala & 14 others	63/100
2nd	Ryght 2023, Anaheim (United States), Series A	Generative AI platform focused on biopharma smart biomedical data	$7.25M	Foothill Ventures, Virtue & 4 others	54/100
3rd	Virtonomy 2019, Munich (Germany), Seed	Provider of virtual patient simulation for medical device development	$3.82M	Dieter von Holtzbrinck Ventures, Startup Autobahn ... & 11 others	39/100
4th	Ebenbuild 2018, Munich (Germany), Seed	Provider of digital twin-based precision therapy solution	$2.78M	Bayern Kapital, HTGF & 2 others	38/100
5th	ELEM Biotech 2018, Barcelona (Spain), Seed	Provider of a simulation based platform for doctors	$2.27M	EIC Fund, GENESIS Biomed & 1 others	38/100
6th	Adsilico 2022, London (United Kingdom), Seed	Provider of insilico trials using virtual patients to assess medical device safety	$4.56M	Parkwalk, Northern Gritstone & 2 others	37/100
7th	Verto Health 2017, Toronto (Canada), Seed	Provider of AI-based digital twin platform for population health management	$1.52M	MaRS IAF, Graphite Ventures & 5 others	37/100
8th	Precision Diagnosis Technology Series B	Provider of digital twin technology for precision medicine	$15.5M	Zhiyou Scientist Fund, Qirong Venture Capital	34/100
9th	Akkure 2016, Dublin (Ireland), Seed	Provider of a blockchain technology based online platform for genomic data analytics	$3.37M	Enterprise Ireland, Digital Transformation Innovation Fund ... Read more	33/100
10th	XY.ai 2017, Palo Alto (United States), Unfunded	Provides software for managing genetic and health data	-	-	31/100